Docetaxel alcohol-free injection - Teikoku Pharma

Drug Profile

Docetaxel alcohol-free injection - Teikoku Pharma

Alternative Names: Docetaxel injection concentrate, non-alcohol formula - Teikoku Pharma

Latest Information Update: 04 Feb 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Teikoku Pharma USA
  • Class Antineoplastics; Small molecules; Taxanes
  • Mechanism of Action Mitosis inhibitors; Tubulin modulators; Tubulin polymerisation promoters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Adenocarcinoma; Breast cancer; Head and neck cancer; Non-small cell lung cancer; Prostate cancer

Most Recent Events

  • 02 Feb 2016 Launched for Adenocarcinoma in USA (IV)
  • 02 Feb 2016 Launched for Breast cancer in USA (IV)
  • 02 Feb 2016 Launched for Head and neck cancer in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top